サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1309765

勃起不全治療装置の世界市場：種類別 (真空収縮装置、陰茎インプラント)・原因別 (血管障害、神経障害)・エンドユーザー別 (病院、外来手術センター)・地域別 (北米、欧州、アジア) の将来予測 (2028年まで)

Erectile Dysfunction Devices Market by Type (Vacuum Constriction Devices, Penile Implants), Source (Vascular, Neurologic disorder), End-user (Hospital, Ambulatory Surgery Center), & Region (North America, Europe, Asia) - Global Forecast to 2028
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 172 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
勃起不全治療装置の世界市場：種類別 (真空収縮装置、陰茎インプラント)・原因別 (血管障害、神経障害)・エンドユーザー別 (病院、外来手術センター)・地域別 (北米、欧州、アジア) の将来予測 (2028年まで)
出版日: 2023年07月12日
発行: MarketsandMarkets
ページ情報: 英文 172 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の勃起不全 (ED) 治療装置の市場規模は、予測期間中に8.8%のCAGRで成長し、2023年の17億米ドルから、2028年には27億米ドルに達すると予測されます。

この市場成長の主な促進要因は、タバコの喫煙率の増加や、アルツハイマー病やパーキンソン病などの神経疾患の増加です。しかし、これらのED治療装置を使用するリスクに関する問題が、勃起不全治療装置市場の成長を抑制しています。

"陰茎インプラントが予測期間中、種類別で最も高い市場シェアを獲得する"

勃起不全治療装置市場を種類別に見ると、陰茎インプラントのセグメントが予測期間中に高い市場シェアを獲得すると予想されています。これは、他のすべての装置と比較して最も成功した治療法であること、自発性・使いやすさ・長期間の耐久性に起因しています。

"クリニックが予測期間中に最も高いCAGRで成長する"

勃起不全治療装置市場をエンドユーザー別に見ると、2022年にはクリニックが市場を独占しました。クリニックの成長を支える要因としては、患者のプライバシーが守られるという利点があること、クリニックが個別治療を提供することで、カスタム型の設定を求める患者を惹きつけることなどが挙げられます。

"北米が予測期間中、地域別で最も高い市場シェアを占める"

世界の勃起不全治療装置市場を地域別に見ると、北米は予測期間中に高い市場シェアが見込まれます。技術的に先進的なED機器の存在と、血管障害や神経障害の有病率の増加が勃起不全治療装置市場の成長を支えています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 価格分析
  • 特許分析
  • バリューチェーン分析
  • サプライチェーン分析
  • エコシステム分析
  • ポーターのファイブフォース分析
  • 規制分析
  • 貿易分析
  • テクノロジー分析
  • 主な会議とイベント (2023年～2024年)
  • 顧客のビジネスに影響を与える動向/混乱
  • 主要な利害関係者と購入基準

第6章 勃起不全治療装置市場：種類別

  • イントロダクション
  • 陰茎インプラント
    • 膨張式インプラント
    • 可鍛性インプラント
  • 真空収縮装置
  • 衝撃波療法
  • その他の種類の装置

第7章 勃起不全治療装置市場：年齢層別

  • イントロダクション
  • 40歳未満
  • 40～60歳
  • 60歳超

第8章 勃起不全治療装置市場：原因別

  • イントロダクション
  • 血管障害・糖尿病
  • 神経障害
  • その他の原因

第9章 勃起不全治療装置市場：エンドユーザー別

  • イントロダクション
  • 病院・外来手術センター (ASC)
  • クリニック

第10章 勃起不全治療装置市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • その他の欧州
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他のアジア太平洋
  • その他の地域
    • ラテンアメリカ
    • 中東・アフリカ

第11章 競合情勢

  • 概要
  • 市場シェア分析
  • 企業評価マトリックス (2022年)
  • スタートアップ/中小企業の企業評価マトリックス (2022年)
  • 競合ベンチマーキング
  • 競合シナリオ

第12章 企業プロファイル

  • 主要企業
    • BOSTON SCIENTIFIC CORPORATION
    • COLOPLAST GROUP
    • RIGICON, INC.
    • PROMEDON GMBH
    • ZEPHYR SURGICAL IMPLANTS
    • OWEN MUMFORD LTD.
    • AUGUSTA MEDICAL SYSTEMS LLC
    • SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD.
    • ZIMMER MEDIZINSYSTEME GMBH
    • MEDISPEC LTD.
    • MTS MEDICAL UG
  • その他の企業
    • NOVAMEDTEK
    • STORZ MEDICAL AG
    • THE ELATOR
    • TIMM MEDICAL
    • OHH-MED MEDICAL LTD.
    • COMPHYA SA
    • DIREXGROUP
    • ADVIN HEALTH CARE
    • GIDDY
    • GLOBAL LIFE TECHNOLOGIES LTD.

第13章 付録

目次
Product Code: MD 8720

The global erectile dysfunction devices market is projected to reach USD 2.7 billion by 2028 from USD 1.7 billion in 2023, at a CAGR of 8.8% during the forecast period. The growth of this market is majorly driven by the growing prevalence of tobacco smoking and the rise in neurological disorders such as Alzheimer's and Parkinson's. However, issues related to the risk of using these ED devices restrain the growth of the erectile dysfunction devices market.

"The penile implant segment accounted for the highest market share in the erectile dysfunction devices market, by type, during the forecast period."

Based on the type segment, the erectile dysfunction devices system market is categorized into vacuum constriction devices, penile implants, shockwave therapy, and other device types. The penile implants segment is expected to witness a high market share during the forecast period. This can be attributed to the most successful treatment compared to all other devices, spontaneity, easy to use, and its durability for long-term.

"Clinics accounted for the highest CAGR during the forecast period."

Based on end users, the erectile dysfunction devices market is segmented into hospitals and ASCs, and clinics, and in 2022, the clinics dominated the market. Factors supporting the growth of clinics include the added advantage of patient privacy and clinics offer individualized care which will attract the patients who are looking for customized setting.

"The North America segment accounted for the highest market share in the erectile dysfunction devices market, by region, during the forecast period."

Based on the region, the global erectile dysfunction devices market is categorized into North America, Europe, Asia Pacific, and Rest of the World. North America is expected to witness a high market share during the forecast period. The presence of technologically advanced ED devices and the increase in the prevalence of vascular and neurological disorders are supporting the growth of the erectile dysfunction devices market.

Breakdown of primary supply-side interviews by company type, designation, and region:

  • By Company Type: Tier 1 (30%), Tier 2 (48%), and Tier 3 (22%)
  • By Designation: C-level (28%), Director-level (33%), and Others (39%)
  • By Region: North America (32%), Europe (30%), Asia- Pacific (23%), and ROW(15%)

Prominent companies include Boston Scientific Corporation (US), Rigicon, Inc. (US), Coloplast Group (Denmark), Promedon GmbH (Argentina), Zephyr Surgical Implants (Switzerland), Owen Mumford Ltd. (UK), Augusta Medical Systems LLC LLC (US), Shenzhen Huikang Medical Apparatus Co., Ltd. (China), Zimmer MedizinSysteme GmbH (Germany), Medispec (US), MTS Medical UG (Germany), NOVAmedtek (Turkey), Storz Medical AG (Switzerland), The Elator (US), TIMM Medical (US), Ohh-Med Medical Ltd. (Israel), Comphya SA (Switzerland), DirexGroup (Germany), Giddy (US), Advin Health Care (India), and Global Life Technologies Ltd. (US).

Research Coverage

This research report categorizes the erectile dysfunction devices market by type, age group, cause, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the erectile dysfunction devices market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the erectile dysfunction devices market. Competitive analysis of upcoming startups in the erectile dysfunction devices market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall erectile dysfunction devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the erectile dysfunction devices market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the erectile dysfunction devices market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the erectile dysfunction devices market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the erectile dysfunction devices market
  • Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like Boston Scientific Corporation (US), Rigicon, Inc. (US), Coloplast Group (Denmark), Promedon GmbH (Argentina), and Zephyr Surgical Implants (Switzerland), among others in the erectile dysfunction devices market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • FIGURE 1 ERECTILE DYSFUNCTION DEVICES MARKET: MARKET SEGMENTATION
    • FIGURE 2 ERECTILE DYSFUNCTION DEVICES MARKET: REGIONAL SEGMENTATION
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 3 ERECTILE DYSFUNCTION DEVICES MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • TABLE 1 KEY DATA FROM PRIMARY SOURCES
    • FIGURE 4 KEY INDUSTRY INSIGHTS
      • 2.1.2.1 Breakdown of primary interviews
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 7 BOTTOM-UP APPROACH: PATIENT-BASED APPROACH
    • FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 9 ERECTILE DYSFUNCTION DEVICES MARKET: TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ANALYSIS
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 RISK ASSESSMENT
  • 2.7 IMPACT OF RECESSION

3 EXECUTIVE SUMMARY

    • FIGURE 11 ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2023 VS. 2028 (USD BILLION)
    • FIGURE 12 ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2023 VS. 2028 (USD BILLION)
    • FIGURE 13 ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2023 VS. 2028 (USD BILLION)
    • FIGURE 14 ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD BILLION)
    • FIGURE 15 REGIONAL SNAPSHOT OF ERECTILE DYSFUNCTION DEVICES MARKET

4 PREMIUM INSIGHTS

  • 4.1 ERECTILE DYSFUNCTION DEVICES MARKET OVERVIEW
    • FIGURE 16 INCREASING PREVALENCE OF PROSTATE CANCER TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE (2022)
    • FIGURE 17 PENILE IMPLANTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2022
  • 4.3 REGIONAL GROWTH OPPORTUNITIES IN ERECTILE DYSFUNCTION DEVICES MARKET
    • FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
  • 4.4 ERECTILE DYSFUNCTION DEVICES MARKET: REGIONAL MIX
    • FIGURE 19 ASIA PACIFIC MARKET TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
  • 4.5 ERECTILE DYSFUNCTION DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES
    • FIGURE 20 DEVELOPING ECONOMIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 21 ERECTILE DYSFUNCTION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing prevalence of prostate cancer
      • 5.2.1.2 Growing incidence of diabetes, kidney and liver diseases, and atherosclerosis
      • 5.2.1.3 High prevalence of tobacco smoking
      • 5.2.1.4 Increasing research and development activities
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Presence of alternative drug treatments
      • 5.2.2.2 Risks associated with use of erectile dysfunction devices
      • 5.2.2.3 High cost and lack of reimbursement policies for erectile dysfunction devices
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Technological advancements
      • 5.2.3.2 Rising investments and grants
      • 5.2.3.3 Expanding market opportunities in emerging countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Survival of small players and new entrants
      • 5.2.4.2 Low awareness regarding prostate health among men
      • 5.2.4.3 Shortage of skilled urologists
  • 5.3 PRICING ANALYSIS
    • TABLE 2 AVERAGE SELLING PRICE OF DEVICES OFFERED BY KEY PLAYERS
  • 5.4 PATENT ANALYSIS
    • FIGURE 22 PATENT ANALYSIS FOR PENILE IMPLANTS (JANUARY 2013-DECEMBER 2022)
    • TABLE 3 LIST OF KEY PATENTS
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 23 VALUE CHAIN ANALYSIS OF ERECTILE DYSFUNCTION DEVICES MARKET
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 24 ERECTILE DYSFUNCTION DEVICES MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 25 ERECTILE DYSFUNCTION DEVICES MARKET: ECOSYSTEM ANALYSIS
    • 5.7.1 ERECTILE DYSFUNCTION DEVICES MARKET: ROLE IN ECOSYSTEM
    • FIGURE 26 KEY PLAYERS IN ERECTILE DYSFUNCTION DEVICES MARKET
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 4 PORTER'S FIVE FORCES ANALYSIS: ERECTILE DYSFUNCTION DEVICES MARKET
    • 5.8.1 THREAT OF NEW ENTRANTS
    • 5.8.2 THREAT OF SUBSTITUTES
    • 5.8.3 BARGAINING POWER OF SUPPLIERS
    • 5.8.4 BARGAINING POWER OF BUYERS
    • 5.8.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.9 REGULATORY ANALYSIS
    • 5.9.1 NORTH AMERICA
      • 5.9.1.1 US
    • TABLE 5 US FDA: MEDICAL DEVICE CLASSIFICATION
      • 5.9.1.2 Canada
    • TABLE 6 CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
    • 5.9.2 EUROPE
    • 5.9.3 ASIA PACIFIC
      • 5.9.3.1 Japan
    • TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
      • 5.9.3.2 China
    • TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.9.3.3 India
  • 5.10 TRADE ANALYSIS
    • TABLE 9 IMPORT DATA FOR MECHANO-THERAPY APPLIANCES, MASSAGE APPARATUS, AND PSYCHOLOGICAL APTITUDE-TESTING APPARATUS, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 10 EXPORT DATA FOR MECHANO-THERAPY APPLIANCES, MASSAGE APPARATUS, AND PSYCHOLOGICAL APTITUDE-TESTING APPARATUS, BY COUNTRY, 2018-2022 (USD MILLION)
  • 5.11 TECHNOLOGY ANALYSIS
  • 5.12 KEY CONFERENCES AND EVENTS IN 2023-2024
    • TABLE 11 ERECTILE DYSFUNCTION DEVICES MARKET: LIST OF KEY CONFERENCES AND EVENTS
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 27 REVENUE SHIFT IN ERECTILE DYSFUNCTION DEVICES MARKET
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ERECTILE DYSFUNCTION DEVICES
    • TABLE 12 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF ERECTILE DYSFUNCTION DEVICES
    • 5.14.2 BUYING CRITERIA
    • FIGURE 29 KEY BUYING CRITERIA FOR ERECTILE DYSFUNCTION DEVICES
    • TABLE 13 KEY BUYING CRITERIA FOR ERECTILE DYSFUNCTION DEVICES

6 ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 14 ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
  • 6.2 PENILE IMPLANTS
    • TABLE 15 PENILE IMPLANTS: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 16 PENILE IMPLANTS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.1 INFLATABLE IMPLANTS
      • 6.2.1.1 Spontaneity of inflatable implants to drive growth
    • TABLE 17 INFLATABLE PENILE IMPLANTS OFFERED BY MARKET PLAYERS
    • TABLE 18 INFLATABLE PENILE IMPLANTS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.2 MALLEABLE IMPLANTS
      • 6.2.2.1 Low maintenance and affordability to drive growth
    • TABLE 19 MALLEABLE PENILE IMPLANTS OFFERED BY MARKET PLAYERS
    • TABLE 20 MALLEABLE PENILE IMPLANTS MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3 VACUUM CONSTRICTION DEVICES
    • 6.3.1 LOWER COST AND ACCESSIBILITY TO DRIVE GROWTH
    • TABLE 21 VACUUM CONSTRICTION DEVICES OFFERED BY MARKET PLAYERS
    • TABLE 22 VACUUM CONSTRICTION DEVICES: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.4 SHOCKWAVE THERAPY
    • 6.4.1 NON-INVASIVE NATURE OF TREATMENT TO DRIVE GROWTH
    • TABLE 23 SHOCKWAVE THERAPY PRODUCTS OFFERED BY MARKET PLAYERS
    • TABLE 24 SHOCKWAVE THERAPY: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.5 OTHER DEVICE TYPES
    • TABLE 25 OTHER DEVICE TYPES OFFERED BY MARKET PLAYERS
    • TABLE 26 OTHER DEVICE TYPES: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)

7 ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP

  • 7.1 INTRODUCTION
    • TABLE 27 ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
  • 7.2 LESS THAN 40 YEARS
    • 7.2.1 INCREASE IN TOBACCO SMOKING TO DRIVE MARKET
    • TABLE 28 LESS THAN 40 YEARS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 40-60 YEARS
    • 7.3.1 INCREASING PREVALENCE OF CVD TO DRIVE GROWTH
    • TABLE 29 40-60 YEARS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.4 MORE THAN 60 YEARS
    • 7.4.1 HIGH PREVALENCE OF VASCULAR DISORDERS TO DRIVE GROWTH
    • TABLE 30 MORE THAN 60 YEARS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)

8 ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE

  • 8.1 INTRODUCTION
    • TABLE 31 ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
  • 8.2 VASCULAR DISORDERS AND DIABETES
    • 8.2.1 VASCULAR DISORDERS AND DIABETES SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
    • TABLE 32 VASCULAR DISORDERS AND DIABETES: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 NEUROLOGICAL DISORDERS
    • 8.3.1 GROWING PREVALENCE OF NEUROLOGICAL DISORDERS TO DRIVE GROWTH
    • TABLE 33 NEUROLOGICAL DISORDERS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 8.4 OTHER CAUSES
    • TABLE 34 OTHER CAUSES: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)

9 ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 35 ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 9.2 HOSPITALS AND ASCS
    • 9.2.1 AVAILABILITY OF REIMBURSEMENT AND MULTIDISCIPLINARY CARE IN HOSPITALS TO DRIVE GROWTH
    • TABLE 36 HOSPITALS AND ASCS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.3 CLINICS
    • 9.3.1 CLINICS SEGMENT TO HOLD LARGER MARKET SHARE
    • TABLE 37 CLINICS: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)

10 ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 38 ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 30 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET SNAPSHOT
    • TABLE 39 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 40 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 41 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 42 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 43 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 44 NORTH AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.1 NORTH AMERICA: RECESSION IMPACT
    • 10.2.2 US
      • 10.2.2.1 US held largest share of North American market in 2022
    • TABLE 45 US: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 46 US: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 47 US: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 48 US: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 49 US: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Growing government investments and continuous technological developments to drive growth
    • TABLE 50 CANADA: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 51 CANADA: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 52 CANADA: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 53 CANADA: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 54 CANADA: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.3 EUROPE
    • 10.3.1 EUROPE: RECESSION IMPACT
    • TABLE 55 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 56 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 57 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 58 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 59 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 60 EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.2 GERMANY
      • 10.3.2.1 Germany to dominate European market during forecast period
    • TABLE 61 GERMANY: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 62 GERMANY: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 63 GERMANY: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 64 GERMANY: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 65 GERMANY: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.3 FRANCE
      • 10.3.3.1 Favorable government initiatives to support growth
    • TABLE 66 FRANCE: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 67 FRANCE: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 68 FRANCE: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 69 FRANCE: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 70 FRANCE: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.4 UK
      • 10.3.4.1 Rising incidence of kidney disorders to drive growth
    • TABLE 71 UK: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 72 UK: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 73 UK: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 74 UK: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 75 UK: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 Aging population to drive growth
    • TABLE 76 ITALY: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 77 ITALY: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 78 ITALY: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 79 ITALY: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 80 ITALY: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Growing awareness of ED to drive growth
    • TABLE 81 SPAIN: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 82 SPAIN: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 83 SPAIN: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 84 SPAIN: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 85 SPAIN: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 86 REST OF EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 87 REST OF EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 88 REST OF EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 89 REST OF EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 90 REST OF EUROPE: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 31 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET SNAPSHOT
    • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
    • TABLE 91 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 92 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 93 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 94 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 95 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 96 ASIA PACIFIC: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.2 JAPAN
      • 10.4.2.1 Japan to hold largest share of Asia Pacific market
    • TABLE 97 JAPAN: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 98 JAPAN: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 JAPAN: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 100 JAPAN: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 101 JAPAN: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.3 CHINA
      • 10.4.3.1 China to register highest growth in Asia Pacific market during forecast period
    • TABLE 102 CHINA: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 103 CHINA: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 104 CHINA: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 105 CHINA: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 106 CHINA: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.4 INDIA
      • 10.4.4.1 Favorable government initiatives to drive growth
    • TABLE 107 INDIA: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 108 INDIA: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 109 INDIA: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 110 INDIA: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 111 INDIA: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.4.5 REST OF ASIA PACIFIC
    • TABLE 112 ROAPAC: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 113 ROAPAC: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 114 ROAPAC: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 115 ROAPAC: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 116 ROAPAC: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
  • 10.5 REST OF THE WORLD
    • 10.5.1 REST OF THE WORLD: RECESSION IMPACT
    • TABLE 117 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET, BY REGION, 2021-2028 (USD MILLION)
    • TABLE 118 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 120 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 121 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 122 REST OF THE WORLD: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.2 LATIN AMERICA
      • 10.5.2.1 High prevalence of chronic diseases to drive growth
    • TABLE 123 LATIN AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 124 LATIN AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 125 LATIN AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 126 LATIN AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 127 LATIN AMERICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)
    • 10.5.3 MIDDLE EAST & AFRICA
      • 10.5.3.1 Increasing healthcare spending to drive growth
    • TABLE 128 MIDDLE EAST & AFRICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 129 MIDDLE EAST & AFRICA: ERECTILE DYSFUNCTION DEVICES MARKET FOR PENILE IMPLANTS, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 130 MIDDLE EAST & AFRICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY AGE GROUP, 2021-2028 (USD MILLION)
    • TABLE 131 MIDDLE EAST & AFRICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY CAUSE, 2021-2028 (USD MILLION)
    • TABLE 132 MIDDLE EAST & AFRICA: ERECTILE DYSFUNCTION DEVICES MARKET, BY END USER, 2021-2028 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 MARKET SHARE ANALYSIS
    • TABLE 133 ERECTILE DYSFUNCTION DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
  • 11.3 COMPANY EVALUATION MATRIX (2022)
    • 11.3.1 STARS
    • 11.3.2 EMERGING LEADERS
    • 11.3.3 PERVASIVE PLAYERS
    • 11.3.4 PARTICIPANTS
    • FIGURE 32 ERECTILE DYSFUNCTION DEVICES MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
  • 11.4 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
    • 11.4.1 PROGRESSIVE COMPANIES
    • 11.4.2 STARTING BLOCKS
    • 11.4.3 RESPONSIVE COMPANIES
    • 11.4.4 DYNAMIC COMPANIES
    • FIGURE 33 ERECTILE DYSFUNCTION DEVICES MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
  • 11.5 COMPETITIVE BENCHMARKING
    • TABLE 134 ERECTILE DYSFUNCTION DEVICES MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS
    • TABLE 135 PRODUCT FOOTPRINT OF KEY PLAYERS
    • TABLE 136 REGIONAL FOOTPRINT OF KEY PLAYERS
    • TABLE 137 ERECTILE DYSFUNCTION DEVICES MARKET: LIST OF KEY START-UPS/SMES
  • 11.6 COMPETITIVE SCENARIO
    • 11.6.1 KEY PRODUCT LAUNCHES
    • TABLE 138 KEY PRODUCT LAUNCHES, JANUARY 2020-JUNE 2023
    • 11.6.2 KEY DEALS
    • TABLE 139 KEY DEALS, JANUARY 2020-JUNE 2023
    • 11.6.3 OTHER KEY DEVELOPMENTS
    • TABLE 140 OTHER KEY DEVELOPMENTS, JANUARY 2020-JUNE 2023

12 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
  • 12.1 KEY PLAYERS
    • 12.1.1 BOSTON SCIENTIFIC CORPORATION
    • TABLE 141 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW
    • FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
    • 12.1.2 COLOPLAST GROUP
    • TABLE 142 COLOPLAST GROUP: COMPANY OVERVIEW
    • FIGURE 35 COLOPLAST GROUP: COMPANY SNAPSHOT (2022)
    • 12.1.3 RIGICON, INC.
    • TABLE 143 RIGICON, INC.: COMPANY OVERVIEW
    • TABLE 144 RIGICON, INC.: PRODUCT LAUNCHES
    • 12.1.4 PROMEDON GMBH
    • TABLE 145 PROMEDON GMBH: COMPANY OVERVIEW
    • 12.1.5 ZEPHYR SURGICAL IMPLANTS
    • TABLE 146 ZEPHYR SURGICAL IMPLANTS: COMPANY OVERVIEW
    • 12.1.6 OWEN MUMFORD LTD.
    • TABLE 147 OWEN MUMFORD LTD.: COMPANY OVERVIEW
    • TABLE 148 OWEN MUMFORD LTD.: OTHER DEVELOPMENTS
    • 12.1.7 AUGUSTA MEDICAL SYSTEMS LLC
    • TABLE 149 AUGUSTA MEDICAL SYSTEMS LLC: COMPANY OVERVIEW
    • 12.1.8 SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD.
    • TABLE 150 SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD.: COMPANY OVERVIEW
    • TABLE 151 SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD.: DEALS
    • TABLE 152 SHENZHEN HUIKANG MEDICAL APPARATUS CO., LTD.: OTHER DEVELOPMENTS
    • 12.1.9 ZIMMER MEDIZINSYSTEME GMBH
    • TABLE 153 ZIMMER MEDIZINSYSTEME GMBH: COMPANY OVERVIEW
    • 12.1.10 MEDISPEC LTD.
    • TABLE 154 MEDISPEC LTD.: COMPANY OVERVIEW
    • 12.1.11 MTS MEDICAL UG
    • TABLE 155 MTS MEDICAL UG: COMPANY OVERVIEW
    • TABLE 156 MTS MEDICAL UG: DEALS
  • 12.2 OTHER PLAYERS
    • 12.2.1 NOVAMEDTEK
    • 12.2.2 STORZ MEDICAL AG
    • 12.2.3 THE ELATOR
    • 12.2.4 TIMM MEDICAL
    • 12.2.5 OHH-MED MEDICAL LTD.
    • 12.2.6 COMPHYA SA
    • 12.2.7 DIREXGROUP
    • 12.2.8 ADVIN HEALTH CARE
    • 12.2.9 GIDDY
    • 12.2.10 GLOBAL LIFE TECHNOLOGIES LTD.
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS